Mainstream

Affirm signals ongoing acceleration in GMV and cardholder spend, eyes further growth through international expansion and AI-driven products

Affirm signals ongoing acceleration in GMV and cardholder spend, eyes further growth through international expansion and AI-driven products

Post ContentafrmRead More

You might also be interested in reading Niagen Bioscience increases FY25 net sales outlook to 25% to 30% year-over-year growth.

August 29, 2025
In Mainstream